Blood markers may forecast MDS outcomes

This study will look at 100 adults with myelodysplastic syndromes (MDS) to see if certain blood test results can help predict how the disease will progress. Researchers will check levels of hemoglobin, albumin, lymphocytes, platelets, and other factors. The goal is to better understand which patients might have a higher risk of serious outcomes, without offering a new treatment.